Business Standard

Moderna surges on S&P 500 inclusion


Moderna jumped to a fresh record after S&P Dow Jones Indices said late on Thursday it plans to add the firm to its benchmark index. The Covid-19 vaccine maker rallied as much as 11% to $288.88 on Friday as the company will replace Alexion Pharmaceut­icals in the S&P 500 Index.

Newspapers in English

Newspapers from India